Pamidronate lines [6]

Indian Pediatrics

Volumn 42, Issue 9, 2005, Pages 959-960

  Srinivasan, Ramesh ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE;

BONE DENSITY; BONE RADIOGRAPHY; CASE REPORT; HUMAN; LETTER; MALE; OSSIFICATION; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; PRESCHOOL CHILD; DRUG EFFECT; FEMUR; RADIOGRAPHY;

ANTINEOPLASTIC AGENTS; BONE DENSITY; CHILD, PRESCHOOL; DIPHOSPHONATES; FEMUR; HUMANS; MALE; OSTEOGENESIS IMPERFECTA;

EID: 25144433918     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of a pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998; 339: 947-952.
2. Rauch F, Travers R, Plotkin H, Glorieux FH. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest. 2002; 110: 1239-1241.